CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients

CX3CL1-CX3CR1 pathway may be one of the future treatment targets to delay the progression of end-stage renal diseases. This study aimed to evaluate the CX3CR gene polymorphism in Egyptian patients with ESRD and its relation to fractalkine blood level. The study included 100 patients with ESRD on dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Asmaa Fathelbab Ibrahim, Asmaa Osama Bakr Seddik Osman, Lamiaa M. Elabbasy, Mostafa Abdelsalam, A. M. Wahab, Maysaa El Sayed Zaki, Radwa Ahmed Rabea Abdel-Latif
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2021/6634365
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850159056382066688
author Asmaa Fathelbab Ibrahim
Asmaa Osama Bakr Seddik Osman
Lamiaa M. Elabbasy
Mostafa Abdelsalam
A. M. Wahab
Maysaa El Sayed Zaki
Radwa Ahmed Rabea Abdel-Latif
author_facet Asmaa Fathelbab Ibrahim
Asmaa Osama Bakr Seddik Osman
Lamiaa M. Elabbasy
Mostafa Abdelsalam
A. M. Wahab
Maysaa El Sayed Zaki
Radwa Ahmed Rabea Abdel-Latif
author_sort Asmaa Fathelbab Ibrahim
collection DOAJ
description CX3CL1-CX3CR1 pathway may be one of the future treatment targets to delay the progression of end-stage renal diseases. This study aimed to evaluate the CX3CR gene polymorphism in Egyptian patients with ESRD and its relation to fractalkine blood level. The study included 100 patients with ESRD on dialysis, 61 males and 39 females with mean age 51.02 ± 7.8 years. The V2491 genotype revealed a significant increase in the frequency of GG genotype in healthy control (83%) compared to patients [69%] with a significant increase in GA in patients [30%] compared to control subjects [15%], P = 0.03. T280M study showed a statistically significant prevalence of TT genotype in healthy control subjects [86%-OR 95% CI 1.7] compared to patients [70%] with a significant increase in the prevalence of TA in patients [29%] compared to control subjects [13%], P = 0.01. There was a significant increase in fractalkine levels in genotypes GA + AA [503.04±224.1] pg/ml compared to genotype GG [423.6 210.3], P = 0.03. Moreover, there was a significant increase in the blood level of fractalkine in genotype TA + AA [498.8 219.6] compared to genotype TT [426.8±212.8], P = 0.05. In conclusion, our study showed that both V2491-GA genotype and T280M-TA are associated with potential risk for end-stage renal disease in Egyptian patients.
format Article
id doaj-art-60409c08ab6f42e4acf92f8fb2018b73
institution OA Journals
issn 2090-214X
2090-2158
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-60409c08ab6f42e4acf92f8fb2018b732025-08-20T02:23:40ZengWileyInternational Journal of Nephrology2090-214X2090-21582021-01-01202110.1155/2021/66343656634365CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian PatientsAsmaa Fathelbab Ibrahim0Asmaa Osama Bakr Seddik Osman1Lamiaa M. Elabbasy2Mostafa Abdelsalam3A. M. Wahab4Maysaa El Sayed Zaki5Radwa Ahmed Rabea Abdel-Latif6Lecturer of Clinical & Chemical Pathology, Faculty of Medicine, Beni Suef University, Beni Suef, EgyptClinical Pathology Department, Faculty of Medicine, Assiut University, Asyut, EgyptDepartment of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura, EgyptMansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, EgyptMansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, EgyptClinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, EgyptLecturer of Clinical & Chemical Pathology, Faculty of Medicine, Beni Suef University, Beni Suef, EgyptCX3CL1-CX3CR1 pathway may be one of the future treatment targets to delay the progression of end-stage renal diseases. This study aimed to evaluate the CX3CR gene polymorphism in Egyptian patients with ESRD and its relation to fractalkine blood level. The study included 100 patients with ESRD on dialysis, 61 males and 39 females with mean age 51.02 ± 7.8 years. The V2491 genotype revealed a significant increase in the frequency of GG genotype in healthy control (83%) compared to patients [69%] with a significant increase in GA in patients [30%] compared to control subjects [15%], P = 0.03. T280M study showed a statistically significant prevalence of TT genotype in healthy control subjects [86%-OR 95% CI 1.7] compared to patients [70%] with a significant increase in the prevalence of TA in patients [29%] compared to control subjects [13%], P = 0.01. There was a significant increase in fractalkine levels in genotypes GA + AA [503.04±224.1] pg/ml compared to genotype GG [423.6 210.3], P = 0.03. Moreover, there was a significant increase in the blood level of fractalkine in genotype TA + AA [498.8 219.6] compared to genotype TT [426.8±212.8], P = 0.05. In conclusion, our study showed that both V2491-GA genotype and T280M-TA are associated with potential risk for end-stage renal disease in Egyptian patients.http://dx.doi.org/10.1155/2021/6634365
spellingShingle Asmaa Fathelbab Ibrahim
Asmaa Osama Bakr Seddik Osman
Lamiaa M. Elabbasy
Mostafa Abdelsalam
A. M. Wahab
Maysaa El Sayed Zaki
Radwa Ahmed Rabea Abdel-Latif
CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
International Journal of Nephrology
title CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
title_full CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
title_fullStr CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
title_full_unstemmed CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
title_short CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
title_sort cx3cr1 at v249m and t280m gene polymorphism and its potential risk for end stage renal diseases in egyptian patients
url http://dx.doi.org/10.1155/2021/6634365
work_keys_str_mv AT asmaafathelbabibrahim cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT asmaaosamabakrseddikosman cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT lamiaamelabbasy cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT mostafaabdelsalam cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT amwahab cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT maysaaelsayedzaki cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients
AT radwaahmedrabeaabdellatif cx3cr1atv249mandt280mgenepolymorphismanditspotentialriskforendstagerenaldiseasesinegyptianpatients